India’s first indigenous Vaccine Against Cervical Cancer launched

HY News 01 September, 2022 04:03 pm IST

Text Size:

India is set to gets its first cervical cancer vaccine, Quadrivalent Human Papillomavirus vaccine (qHPV) today i.e. 1 September. The most awaited vaccine will be launched by the Union Minister of State (Independent Charge) Science & Technology Jitendra Singh at IIC Delhi.

The Drugs Controller General of India (DCGI) had on 12 July granted market authorisation to Serum Institute of India (SII) to manufacture an indigenously-developed vaccine against cervical cancer. It is reported that the SII's vaccine is likely to be available at a much affordable rate. At present, the country is fully dependent on foreign manufacturers for the HPV vaccine.

The World Health Organization (WHO) estimates that India bears a fifth of the globe's cervical cancer burden, with 1.23 lakh new cases and 67,000 fatalities per year. By producing antibodies against HPV, this vaccination prevents the 6, 11, 16, and 18 strains, according to the government analysis.

Health Benefits of Walking

India wins UN award for initiative against hypertension

Related News

Leave Comments